Mumbai-headquartered - Latest News Update, Information, Photos & Videos on Mumbai-headquartered at Lokmat Times

Mumbai, June 20 Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator's approval.It will be available under the brand name FabiFlu as a prescription-based medication for Rs 103 per tablet, with recommended dose of 1,800 mg twice a day on day 1 and 800 mg twice a day up to 14th day, according to the Mumbai-headquartered global pharmaceutical company.Glenmark received the approval for manufacturing and marketing Favipiravir from the Drugs Controller General of India (DCGI) on Friday."The approval has come at a time when cases in India are spiralling, putting tremendous pressure on our healthcare system," Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals, said in a statement."We hope the availability of an effective treatment, such as FabiFlu, will help assuage this pressure considerably and offer patients in India a much-needed and timely therapy option," Saldanha said.Favipiravir is backed by strong clinical evidence, showing encouraging results in patients with mild to moderate Covid-19. It offers broad spectrum RNA virus coverage with clinical improvement noted in 20-90 plus age group.Patients from over 10 leading government and private hospitals were enrolled for the study.Favipiravir could be used for Covid-19 patients with comorbid conditions, like diabetes and heart disease, the company said and added, it would offer rapid reduction in viral load within four days, and faster symptomatic and radiological improvement.Glenmark has developed the active pharmaceutical ingredient (API) and formulation for FabiFlu through in-house R&D team.Glenmark was the first company in India to receive the drug regulator's approval to conduct phase-3 clinical trial of Favipiravir antiviral tablets for Covid-19 patients.Favipiravir is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation.( With inputs from IANS )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Mumbai-HeadquarteredFOLLOW

Mumbai-headquartered, Latest News

Business :Smartr Logistics offers same-day Interstate Express Delivery: A first in India's Express Logistics Industry

Mumbai headquartered Smartr Logistics, a trademark of Smart Express Private Limited, has carved a niche in the express logistics industry by offering same-day interstate delivery. The logistics firm has been executing multiple inter-state same-day de ...

Business :Smartr Logistics plans to double operations to 100 cities in 2022

Mumbai headquartered Smartr Logistics, a trademark of Smart Express Private Limited, has a robust expansion plan for 2022. ...

National :IHW Council launches COVID relief project for frontline workers, their families

To boost the morale of the frontline workers in the country, the Integrated Health and Wellbeing Council (IHW Council) launched a COVID-19 relief project for frontline workers and their families. ...

Business :Multidisciplinary leaders join the advisory board of Great Manager Institute

Great Manager Institute, the Mumbai-headquartered company focused on cracking the code of people management, announces the formation of its new advisory board. ...

Lifestyle :Preserving world-famous Ajanta Cave paintings using AI

In an initiative that is unique in every sense of the word, artificial intelligence (AI) has now come to the aid of digitally preserving the world-famous, 2nd Century BC Ajanta cave paintings, so that they last for many lifetimes, safe from disasters ...

Health :Glenmark launches Covid-19 drug in India

Mumbai, June 20 Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after ... ...